Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Country Overviews Market Research Reports

Titlepublishedprice

Iraq Pharmaceuticals and Healthcare Report Q4 2016

By Business Monitor International
"...... international support will remain key to ensuring the population's access to healthcare. Indeed, the domestic sector's capabilities will remain limited for the foreseeable future. The Iraqi government's ability to attract investmen......"
21-Sep-2016$1295

Oman Pharmaceuticals and Healthcare Report Q4 2016

By Business Monitor International
"...... nes are reduced in price, however the impact on drugmaker's profit margins will continue to come under question. Nonetheless, Oman's evolving demographic and epidemiological profile will act as key drivers of growth within the count......"
21-Sep-2016$1295

Pakistan Pharmaceuticals and Healthcare Report Q4 2016

By Business Monitor International
"...... ement system hinders efforts to establish sales strategy. These factors result in an unattractive medicines market that will incentivise multinational pharmaceutical firms to invest in other emerging markets such as China or Indones......"
21-Sep-2016$1295

Puerto Rico Pharmaceuticals and Healthcare Report Q4 2016

By Business Monitor International
"...... o's Medicaid funding limitations over the coming months, the increasing risk posed by the Zika virus outbreak in the territory will push for a rise in healthcare funding to become a priority. That said, market growth rates in several......"
21-Sep-2016$1295

Serbia Pharmaceuticals and Healthcare Report Q4 2016

By Business Monitor International
"...... ons Pharmaceuticals: RSD91.42bn (USD840mn) in 2015 to RSD88.08bn (USD766mn) in 2016; -3.7% in local currency terms and -8.8% in US dollar terms. Forecast unchanged from Q316. Healthcare: RSD405.24bn (USD3.73bn) in 2015 to RSD414.284......"
21-Sep-2016$1295

Singapore Pharmaceuticals and Healthcare Report Q4 2016

By Business Monitor International
"...... se of pharmaceuticals as mobile applications play a greater role. Consequently, drugmakers will have to adapt their marketing strategies to account for these shifts in the patient journey to capture the commercial opportunities in the Sin......"
21-Sep-2016$1295

Sudan and South Sudan Pharmaceuticals and Healthcare Report Q4 2016

By Business Monitor International
"...... aring will affect both governments' abilities to fund new healthcare infrastructure projects. The governments' plans to improve domestic pharmaceutical manufacturer capabilities will attempt to reduce ongoing medicine shortages, how......"
21-Sep-2016$1295

Sweden Pharmaceuticals and Healthcare Report Q4 2016

By Business Monitor International
"...... ong term, pushing costs onto a population with fewer young people to financially support the elderly will ultimately work to reduce the consumption of higher-value innovative pharmaceuticals. Headline Expenditure Projections ?......"
21-Sep-2016$1295

Switzerland Pharmaceuticals and Healthcare Report Q4 2016

By Business Monitor International
"...... government will to continue to enforce measures that restrict growth in medicine sales - including the roll-out of initiatives that enforce the cost effective pricing and rational prescribing of medicines. Headline Expenditure Proje......"
21-Sep-2016$1295

Chile Pharmaceuticals and Healthcare Report Q4 2016

By Business Monitor International
"...... ch as the 'People's Pharmacy' to improve patients' access to innovative medicines. It will also boost volume sales for multinational drugmakers in Chile. Headline Expenditure Projections Pharmaceuticals: From CLP2.2trn (USD3.3......"
14-Sep-2016$1295